SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,100,189 | -83.0% | 116,319 | -84.0% | 0.61% | -80.1% |
| Q2 2023 | $83,175,303 | +87.9% | 726,295 | +126.1% | 3.08% | +69.2% |
| Q1 2023 | $44,272,236 | +104.6% | 321,209 | +92.4% | 1.82% | +33.2% |
| Q4 2022 | $21,638,564 | +140.9% | 166,990 | +102.8% | 1.37% | +12.4% |
| Q4 2018 | $8,984,000 | -63.2% | 82,327 | -45.5% | 1.22% | -26.3% |
| Q3 2018 | $24,384,000 | +218.1% | 150,974 | +160.3% | 1.65% | +93.7% |
| Q2 2018 | $7,666,000 | -13.8% | 58,000 | -51.7% | 0.85% | -32.2% |
| Q1 2018 | $8,891,000 | +3.1% | 120,000 | -22.6% | 1.26% | +11.2% |
| Q4 2017 | $8,624,000 | – | 155,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |